Most health care documents I edit are a few steps removed from the caregiver: usually they pertain to something like an analysis of midwives’ business practices or a review of pharmacists’ attitudes to new treatments for their clients.
In “New Perspectives from China on HIV Rheumatic Manifestations,” by Evelyn V. Hess and Alexander D. Brown, however, I got to edit a journal article written by two doctors. Their editorial was published in the August 2007 edition of The Journal of Rheumatology, a monthly peer-review.
Here’s an excerpt:
What are the take-to-the-clinic messages of this study and how should we integrate these intriguing findings for HIV patients with rheumatic manifestations in our clinics? Despite tremendous advances in treatment, HIV and its rheumatic manifestations remain a significant cause of morbidity and mortality. Zhang and colleagues’ study provides further evidence of the remarkable shifts in the frequency and nature of HIV associated rheumatic complications. Thus, vigilance and careful attention by physicians to these emerging patterns of rheumatic disease in the HIV population are essential to provide the best possible diagnosis and treatment for this population.